Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 29:10:2789.
doi: 10.3389/fimmu.2019.02789. eCollection 2019.

Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection

Affiliations

Lower Interferon Regulatory Factor-8 Expression in Peripheral Myeloid Cells Tracks With Adverse Central Nervous System Outcomes in Treated HIV Infection

Michelle L D'Antoni et al. Front Immunol. .

Abstract

Cognitive dysfunction persists in 30-50% of chronically HIV-infected individuals despite combination antiretroviral therapy (ART). Although monocytes are implicated in poor cognitive performance, distinct biological mechanisms associated with cognitive dysfunction in HIV infection are unclear. We previously showed that a regulatory region of the interferon regulatory factor-8 (IRF8) gene is hyper-methylated in HIV-infected individuals with cognitive impairment compared to those with normal cognition. Here, we investigated IRF-8 protein expression and assessed relationships with multiple parameters associated with brain health. Intracellular IRF-8 expression was measured in cryopreserved peripheral blood mononuclear cells from chronically HIV-infected individuals on ART using flow cytometry. Neuropsychological performance was assessed by generating domain-specific standardized (NPZ) scores, with a global score defined by aggregating individual domain scores. Regional brain volumes were obtained by magnetic resonance imaging and soluble inflammatory factors were assessed by immunosorbent assays. Non-parametric analyses were conducted and statistical significance was defined as p < 0.05. Twenty aviremic (HIV RNA<50 copies/ml) participants, 84% male, median age 51 [interquartile range (IQR) 46, 55], median CD4 count 548 [439, 700] were evaluated. IRF-8 expression was highest in plasmacytoid dendritic cells (pDCs). Assessing cognitive function, lower IRF-8 density in classical monocytes significantly correlated with worse NPZ_learning memory (LM; rho = 0.556) and NPZ_working memory (WM; rho = 0.612) scores, in intermediate monocytes with worse NPZ_LM (rho = 0.532) scores, and in non-classical monocytes, lower IRF-8 correlated with worse global NPZ (rho = 0.646), NPZ_LM (rho = 0.536), NPZ_WM (rho = 0.647), and NPZ_executive function (rho = 0.605) scores. In myeloid DCs (mDCs) lower IRF-8 correlated with worse NPZ_WM (rho = 0.48) scores and in pDCs with worse NPZ_WM (rho = 0.561) scores. Declines in IRF-8 in classical monocytes significantly correlated with smaller hippocampal volume (rho = 0.573) and in intermediate and non-classical monocytes with smaller cerebral white matter volume (rho = 0.509 and rho = 0.473, respectively). IRF-8 density in DCs did not significantly correlate with brain volumes. Among biomarkers tested, higher soluble ICAM-1 levels significantly correlated with higher IRF-8 in all monocyte and DC subsets. These data may implicate IRF-8 as a novel transcription factor in the neuropathophysiology of brain abnormalities in treated HIV and serve as a potential therapeutic target to decrease the burden of cognitive dysfunction in this population.

Keywords: HIV-1; IRF-8; anti-retroviral therapy; central nervous system; cognition; dendritic cells; interferon; monocytes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IRF-8 expression on monocytes and dendritic cells. (A) Intracellular IRF-8 levels, expressed as geometric mean fluorescence intensity (GMF), on monocyte subsets (classical, intermediate, and non-classical) and dendritic cell (DC) subsets (myeloid and plasmacytoid). The hash mark indicates the median and error bars are the interquartile range. **p < 0.01; ***p < 0.001, ****p < 0.0001. (B) Representative histograms of IRF-8 expression in each subset.
Figure 2
Figure 2
Correlations between IRF-8 expression on myeloid cells and neuropsychological testing. Correlations between IRF-8 expression of (A) classical, (B) intermediate, and (C) non-classical monocytes, and (D) myeloid and (E) plasmacytoid dendritic cells and NPZ scores.
Figure 3
Figure 3
Correlations between IRF-8 expression on myeloid cells and regional brain volumes. Correlations between IRF-8 expression of (A) classical, (B) intermediate, and (C) non-classical monocytes and regional brain volumes corrected for intracranial volume.
Figure 4
Figure 4
Correlations between IRF-8 expression on myeloid cells and soluble inflammatory markers. Correlations between IRF-8 expression of (A) classical, intermediate, and non-classical monocytes, (B) myeloid and (C) plasmacytoid DCs and soluble intercellular cell adhesion molecule-1 (sICAM-1). (D) Correlation between IRF-8 expression in intermediate monocytes and plasma interferon-gamma (IFN-γ) level.

Similar articles

Cited by

References

    1. Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, et al. . Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr. (2009) 52:56–63. 10.1097/QAI.0b013e3181af83d6 - DOI - PubMed
    1. Heaton RK, Clifford DB, Franklin DR, Jr, Woods SP, Ake C, Vaida F, et al. . HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. (2010) 75:2087–96. 10.1212/WNL.0b013e318200d727 - DOI - PMC - PubMed
    1. Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, et al. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. (2004) 10:317–31. 10.1017/S1355617704102130 - DOI - PubMed
    1. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, et al. . Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV neurobehavioral research center group. Arch Neurol. (1997) 54:416–24. 10.1001/archneur.1997.00550160054016 - DOI - PubMed
    1. Ickovics JR, Hamburger ME, Vlahov D, Schoenbaum EE, Schuman P, Boland RJ, et al. . Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study. JAMA. (2001) 285:1466–74. 10.1001/jama.285.11.1466 - DOI - PubMed

Publication types

MeSH terms

Substances